General Comments / Chat, page-7527

The point you raise around alopecia is an interesting one. Especially around breast cancer. On the table above, Zantrene shows 83% of patients having zero to mild hair loss. Yet Dox had 74% of patients having moderate to severe hair loss. I imagine if those historical results are shared with women in the breast cancer trials, that alone would significantly improve our patient take-up. There’s an entire industry catering to cancer treatment wigs for women and anything we can do to help the emotional side of treatment would be a huge psychological win, let alone the obvious medical benefits of Zantrene